57
Views
24
CrossRef citations to date
0
Altmetric
Research Article

RADIOTHERAPEUTIC MANAGEMENT OF INTRACRANIAL EPENDYMOMA

Pages 295-308 | Published online: 09 Jul 2009

  • Miller RW, Young JL. Novakovic B. Childhood cancer. Cancer. 1994;75:395-405.
  • Pollack IF. Current concepts: brain tumors in children. NEngl J Med. 1994;331:1500-1507.
  • Kleihues P. Cavenec WK. Pothology and Genetics of Tumours of the Nervous System. Lyon (France): International Agency for Research on Cancer Press: 2000.
  • Reardon DA, Entrekin RE. Sublett J, et al. Chromosome arm 6q loss is the most common recurrent autosomal alteration detected in primary pediatric ependymoma. Genesnn Chromosomes Cancer: 1999:2.1:230-237.
  • Goldwein JW, Leahy JM, Packer RJ. et al. lntracranial ependymomas in children, Int J Radialinl Oncl Biol Phys. 1990;19:1.197-1502.
  • Horn B. Heideman R. Geyer R. et al. A multi-institutional retrospective study of intracranial ependymoma in children: identification of risk factors. J Pediats Hematol h 1999:21:203-211.
  • Duffner PK, Krischer JP, Sanfnrd RA, et al. Prognostic factors in infants and very young children with intracranial ependymomas. Pediatr Neurosurg. 1998;28:215-222.
  • Comi AM, Backstrom JW, Burger PC, Duffner PK. Clinical and neurological findings in infants with intracranial ependymomas. Pediatr Neutrol. 1998;18;23:-29.
  • Robertson PL. Zeltzer PM,Boyett JM, et al. Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group. J. Neurosurg. 1998;88:695-703.
  • Rousseau P, Habrand JL, Sarragin D, et al. Treatment of intracranial ependymomas children: review of a 15-year experience. Int J Radiat Oncol Biol Phs. 1993;28:381-386.
  • Imhof HG, Hany M, Wiestler OD, Glanzmann C. Long-term follow-up in 39 patients with an ependymoma after surgery and irradiation. Strahlenther Onkol. 1992;168:513-519.
  • Kovalic JJ. Flaris N, Grigsby PW, Pirkowski M. Simpson JR, Roth KA. Intacranial ependymoma longterm outcome, patterns of failure. J Neurooncol. 1993;15:125-131.
  • Papadopoulos DP, Giri S, Evans RG. Prognostic factor management of intracranial ependymomas. Anticancer Res. 1992;10:689-692.
  • Paulino AC, Wen BC, Hnssey DH, Zhen WK, Mayr NA, Menezes AH. Cancer J Sci Am. 2000;6:104-105 (abstract).
  • Perilongo G, Massimino M, Sotti G, et al. Analyses of piognostic factors in a retrospective review of 92 children with ependymoma: Italian Pediatric Nenro-Oncology Group. Med Pediatr Oncol, 1997:29: 79-85.
  • Vannytsel LJ, BesslI EM, Ashley SE, Bloom HJG, Brada M. Intracranial ependmoma: long-term results of a policy of surgery and radiotherapy. Int J Radiat Oncol Biol Phys. 1992:23:313319.
  • Merchant TE. Haida T, Wang MH, FinlayJL. Leibel SA. Anaplastic ependymonia: treatement of 'pediatric patients with or without craniospinal radiation therapy. J.Neurosurg. 1997;86:943-949.
  • Timmermann B, Kortmann RD, Kuhl J. et al. Combined postoperative irradiation and chemotherapy for anaplaslic ependymomas in childhood: results of the German prospective trials HIT 88/89 and HIT 91. Int J Radiat Oncol Biol Phys. 2000;46:287-295.
  • Sutton LN, Goldlwein J, Perilongo G, et al. Prognostic factors in Childhood ependymomas. Pediatr Neurosurg. 1990;16:57-65.
  • Healey EA, Barnes PD, Kupsky WJ. et al. The prognostic significance of postoperative residual tumor in ependymoma. Neurosurgery. 1991;28:666-672.
  • Mork SJ, Loken AC, Ependymomas: a follow-up study of 101 Cases. Cancer. 1977;40:907-915.
  • Ferrante L, Mastronardi L, Schettini G, Lunardi P, Fortuna A. Fourth ventricle ependyniomas: a study of 20 cases with survival analysis. Acta Neurochir. 1994;131:67-74.
  • Palma L, Cell P, Cantore G. Supratentorial ependymomas of the first two decades of life: long-lerm follow-up of 20 cases (including two subependymomas) Neurosurgery. 1993;32:169-175.
  • Paulino AC. The local field in infratenroial eprndymoma: does the entire posterior fossa need to be treated? Int J Radial Oncol Biol Phys. 2001;49:757-761.
  • Hukin J. Epstein F, Lefton D, Allen J.Treatment of intracranial ependymoma by surgery alone. Pediatr Neurosurg. 1998;29:40-45.
  • Duffner PK, Horowitz ME, Krischer JP, et al. Postoperative chemotherapy and delayed radiation in children less than three years of age with malignant brain tumors. N Engl J Med. 1993;328:1725-1731.
  • Packer RJ, Geyer R, Jennings M, et al. Disease control in infants and young children with medulloblastoma and ependymomas using chemotherapy alone: a Children's Cancer Group study. Ann. Neurol. 1998;44:537 (abstract).
  • Grill J. Deley ML, Gambarelli D, et al. Postoperative chemotherapy without irradiation for ependymoma in children under 5 years of age: a multicenter trial of the French Society of Pediatric Oncology. J Clin Oncol. 2001:19:1288-1296.
  • Bloom HJG. Intracranial tumors: response and resistance to therapeutic endeavors. 1970-1980. Int J Radiat Oncol Biol Phys. 1982;8:1083-1113.
  • Salazar OM. A better understanding of CNS seeding and a brighter outlook for postoperatively irradiated patients with ependymomas, Int J Radiat Oncol Biol Phys. 1983:9:1231-1234.
  • Salazar OM, Castro-Vita H, VanHoutte P, Rubin P, Aygun C. Improved survival in cases of intracranial ependymoma after radiation therapy: late report and recommendations. J Neurosurg. 1983;59:652659.
  • Vanuytsel L, Brada M. The role of prophylactic spinal irradiation in localized intracranial ependymoma. Int J Radiat Oncol Biol Phys. 1991;21:825-830.
  • Goldwein JW, Com BW, FinlayJL, Packer RJ, Rorke LB, Sehut L. Is craniospinal irradiation required to cure children with malignant (anaplastic) intracranial ependymomas? Cancer. 1991;67:27662771.
  • Paulino AC, Wen BC. The significance of radiotherapy treatment duration in intracranial ependymoma. Int J Radiat Oncol Biol Phys. 2000;47:585-589.
  • Pollack IF, Gerszten PC, Martinez AJ, Lo KH, Shutz B, Albright, et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neutrosurgery. 1995;37:655-666.
  • Jefferies S, Rajan B, Ashley S, Traish D, Brada M. Haematological txicity of cranio-spinal irradiation. Radiother Oncol. 1998;48:23-27.
  • Grill J, Renaux VK, Bulteau C, et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys. 1999;45:137-145.
  • Fukunaga-Johnson N, Sandler HM, Marsh R, Manel MK. The use of 3D conformal radiotherapy (3D CRT) to spare the cochlea in patients with medulloblastoma. Int J Radiat Oncol Biol Phys. 1998;41: 77-82.
  • Loeffler JS, Kooy HM, Tarbell NJ. The emergence of conformal radiotherapy: special implications for pediatric neuro-oncology. Int J Radiat Oncol Boil Phys. 1999;44:237-238.
  • Paulino AC, Narayana A, Mohideen MN, Jeswani S. Posteriora fossa boost in medulloblastoma: an analysis of dose to surrounding structures using 3-dimensional (conformal) radiotherapy. Int J Radiat Oncl Biol Phys. 2000:46:281-286.
  • Kim YH, Fayos JV. lntracraniat ependymomas. Radiology. 1977; 124:805-808.
  • Stuben G, Stuschke M, Kroll M, Havers W, Sack H. Postoperative radiotherapy of spinal and intracranial ependymomas: analysis of prognostic factors. Radiother Oncol. 1997;45:3-10.
  • Garrett PG, Simpson WJK. Ependymomas: results of radiation therapy. Int J Radiat Oncol Biol Phys. 1983;9:1121-1124.
  • Chiu JK, Woo SY, Ater J, Connelly J, Bruner JM, Maor MH. Intracranial ependymoma in children: analysis or prognostic factors. J Neuro Oncol. 1992;13:283-290.
  • Kovnar E, Curran W, Tomita T, et al. Hyperfractionated irradiation for childhood ependymoma: improved local control in subtotally resected tumors. Childs Nerv Syst. 1998;98;14:569 (abstract).
  • Aggarwal R, Yeung D, Kumar P, Muhlbauer M, Kun LE. Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependytmoma. Radiother Oncol. 1997;43:269-273.
  • Evans AE. Anderson JR, Lefkowitz-Boudreaux IB, Finlay JL. Adjuvant chemotherapy of childhood posterior fossa ependymoma: cranio-spinal irradiation with or without adjuvant CCNU, vincristine and prednisone: a Children's Cancer Group study. Med Pediatr Oncol. 1996:27:8-14.
  • Needle MN, Goldwein JW, Grass J. et al. Adjuvant chemotherapy for the treatment of intracranial ependymoma of childhood. Cancer. 1997:80:341-347.
  • Bouffet E, Perilongo G, Carote A, Massimino M. Intracranial ependymomas in children: a critical review of prognostic factors and a plea for cooperation. Med Pediatr Oncol. 1998;30:319-331.
  • Van Eys J, Cangir A, Coody D, Smith B. MOPP regimen as primary chemotherapy for brain tumor in infants, J. Neurooncol. 1985;3:237-243.
  • Ayan I, Darendelilen E, Kebudi R, et al. Evaluation of response to postradiation eight in one chemotherapy in childhood brain tumors.J Neurooncol. 1995;26:65-72.
  • Donaldson SS, Meza JL, Breneman J, et al. Results from the IRS IV randomized trial of hyperfractionated radiation in children with rhabdomyosarcoma. InIt J Radiat Oncol Biol Phys. 200;48(S):178 (abstract).
  • Mandell LR, Kadata R, Freeman C, et al. There is no role for hyperfractionated radiotherapy in the management of children with newly diagnosed diffuse intrinsic brainstem tumors: results of a Pediatric Oncology Group Phase III trial comparing conventional vs. hypertracrionated radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:959-964.
  • Wara WM, Weil MD, Larson DA, Lamborn K, Edwards M.S. Hyperfractionated radiotherapy of medulloblastoma. Int J Radiat Oncnl Biol Phys. 1999;45:212 (abstract).
  • Merchant TE, Thompson SJ, Williams T. Sontag MR, Zhu Y, Kun LE. Preliminary results from a phase Il trial of conformai radiation therapy for localized pediatrie brain tumors, Int J Radiat Oncol Biol Phys. 2000;48(S):180 (abstract).
  • Boyer AL, Geis P, Grant W, Carol M. Modulated conformal therapy for head and neck tumors. Int J Radiat Oncol Phys. 1997;39:227-236.
  • Stein J, Botfield T, Dorschel B, Schlegel W. Dynamic x-ray compensation for conformat radiotherapy by means of multi-leaf collimation. Radopther Oncol. 1994;32:163-173.
  • Xia P, Fn KK, Wong GW, Akazawa C, Verhey LJ. Comparison of treatment plans involving intensity modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48:329-337.
  • Benk V, Clark GB, Sonhami L, et al. Stercotactic radiation in primary brain tumors in children and adolescents. Pediatr Neurosurg. 1999;31:59-64.
  • Jawahar A. Kondziolka D, FlickingerJC, Lunsfbrd LD. Adjuvant stereotactic radiosurgery for anaplastic ependymoma. Stereotact Funct Neurosurg. 1999;73:23-30.
  • Stafford SL, Pollock BK, Foote RL, Gorman DA, Nelson DF, Schomberg PJ. Stercotactic radiosurgery for recurrent ependymoma Cancer. 2000:88:870-875.
  • Goldwein JW, GlauserTA, Packer RJ, et al. Recurrent intracranial ependymomas in children: survival, patterns of failure and prognostic factors. Cancer. 1990;66:557-563.
  • Dutton SC, Goumnerova L, Billett AL, et al. Fractionated steteotactic radiotherapy for localized pediatrie brain tumors: results of a prospective study. Int J Radiat Oncol Biol Phys. 1999;45(S)234 (abstract).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.